The CIIE is a hopeful event - every edition can witness the approval and launch of innovative drugs, allowing patients who have been waiting for antidotes to see the dawn and regain their lives.
So many "life-saving" achievements are touching, but the impact brought by the CIIE is not limited to that. In terms of survival, more detailed needs and care can also be seen and satisfied here.
Hyperlipidemia is a common chronic disease, and the current mainstream treatment method is to take statins every day. This action is not difficult, but day after day, there will inevitably be times of laziness or forgetting.
On Novartis' booth, there is a drug called "LeCowei". This is the world's first and currently the only small interfering RNA drug used to reduce LDL-C. Compared to statins, it can effectively lower cholesterol in the long term, is more medication friendly, and has fewer side effects. After the first injection, a booster shot is needed in the third month, and then only once every six months is needed to effectively reduce LDL-C by 61%.
After listening to the introduction, a young exhibitor only said two words: "That's great" and immediately inquired about where to get the injection, hoping to bring their family over.
This year is the seventh CIIE, and I really hope that more and more people can be "poked" by a certain exhibit and sincerely say "really good"!